Latin America: An Untapped Clinical Trials Resource

Benefits of the increasing globalization of clinical trials include access to a larger patient population for recruitment, more treatment-naïve patients and patients with geographically disparate diseases, as well as the ability to offer healthcare to underserved populations, often at lower costs. However, start-up times vary widely by country, and some countries that are relatively new to clinical trials are still developing and refining their regulatory requirements and processes.

Download this white paper to understand the benefits and challenges of conducting studies in Latin America in addition to some recent changes that could expedite regulatory timelines.